27
Mon, May
76 New Articles

Dorda, working with Linklaters, Kromann Reumert, and Wilson Sonsini Goodrich & Rosati, has advised Novo Holdings on its acquisition of Single Use Support. E+H advised the Single Use Support founders and Binder Groesswang advised Danaher on the sale side. Kirkland & Ellis reportedly advised Danaher as well.

In Serbia, most of the exclusivity arrangements between pharma companies need to be, prior to their implementation, individually exempt by the Serbian Competition Authority (“SCA”). Most recently, the SCA issued two decisions in the individual exemption process. In one it denied, while, in the other it only conditionally approved individual exemptions for exclusive distribution agreements between pharmaceutical companies. These developments show a noticeable shift in the SCA’s stand towards exclusivity arrangements with the SCA taking a stringent approach, limiting the parties' ability to contract exclusivity arrangements in the sector.

Filip & Company has advised the Centrokinetic orthopedics and medical rehabilitation network together with its shareholder, the Agista investment fund, on their acquisition of a 70% stake in the Socrates clinic in Timisoara, Romania. Timisoara-based sole practitioner Diana Pavel Cios reportedly advised the sellers.

CMS, working with Harneys Cyprus, has advised the European Bank for Reconstruction and Development on a EUR 22 million loan to the Cyprus-based Farmak Group and Ukraine's JSC Farmak for the acquisition of Poland's Symphar and the upgrade of JSC Farmak's IT systems.

More Articles ...

Our Latest Issue